Brief: Alembic Pharmaceuticals Gets USFDA Final Approval For Dabigatran Etexilate Capsules
13/08/2024 07:33
Aug 13 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* ALEMBIC PHARMACEUTICALS LTD - RECEIVES USFDA FINAL
APPROVAL FOR
DABIGATRAN ETEXILATE CAPSULES
Source text for Eikon: ID:nBSE8Nj9gG
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand